Skip to Content
Digital Diagnostics' flagship product has been renamed LumineticsCore™ Read More
...
Read More
Artificial intelligence shows promise in medicine, but there are recognized drawbacks and risks
Autonomous AI systems in the face of liability, regulations, and costs
Fostering a Culture of Innovation and Collaboration: Inside Digital Diagnostics’ Third Company Hackathon
Addressing Bias in Artificial Intelligence for Health Equity
OSF HealthCare Increasing Access to Innovative Patient Care with Artificial Intelligence Diagnostic System
Real World Evidence Highlighting the Benefits of Autonomous AI Diagnostics Presented at ARVO 2023
How John Bertrand Became a Guiding Force in Health Care Technology
Diabetic Retinopathy Prevalence at an All-Time High According to Recent Study
Doing AI the Right Way, Not The Fast or Easy Way
Point-of-Care Testing with Autonomous AI Preserves Patient Eyesight and Drives Healthcare Equity: White Paper
Digital Diagnostics Celebrate the Nashville Health Care Council Fellows 2023 Graduates
Determinants for Scalable Adoption of Autonomous AI in the Detection of Diabetic Eye Disease in Diverse Practice Types: Key Best Practices Learned Through Collection of Real-World Data
Digital Diagnostics launches LumineticsCore system in southeast US
AI in Ophthalmology: From code to clinic
AI and The Disruption of Healthcare
Where AI fits into the health care space
4 Benefits of Ophthalmic Imaging Technology for Diabetic Retinopathy
Autonomous AI Prevents Blindness by Increasing Eye Exam for Diabetes Access for So-Cal Patients: White Paper
Eye Anatomy: The Structures of the Eye and Their Functions
OSF Healthcare’s Journey with LumineticsCore
Newly Published Policy Model: Effectiveness of Artificial Intelligence Diagnosis in Preventing Vision Loss from Diabetes
Eye-Opening AI Changes the Way Patients are Diagnosed
Digital Diagnostics Expands to Lab Settings Increasing Access to Care
LumineticsCore: A letter from the CEO
Digital Diagnostics and Tamer Healthcare Announce Strategic Partnership in the Kingdom of Saudi Arabia
New AI technology helps central Illinois diabetics
Health Tech: Dr Michael Abramoff Of Digital Diagnostics On How Their Technology Can Make An Important Impact On Our Overall Wellness
Three Areas of Health Tech That Could Withstand a Turbulent Economy
Nashville Health Care Council Fellows Announces Class of 2023
Digital Health’s Newest Funding Hub is in the United Arab Emirates
Digital Diagnostics Named to the 2022 CB Insights’ Digital Health 150 List
Corridor Business Journal Tells Digital Diagnostics’ Story Through the Years
Leading with Speed and Grace – An Interview with Seth Rainford
Digital Diagnostics Closes $75 million Series B Funding Round led by KKR
Healthcare Upside/Down: The Retinator
Baxter’s (BAX) ST Set Receives FDA Nod, to Boost Patient Outcome
A New Vision for Diabetic Eye Exams in Primary Care Offices
Digital Diagnostics Partners With Archwell Health on Early Detection of Diabetic Retinopathy
Digital Diagnostics, Kingdom of Saudi Arabia, Sign Intent to Provide Preventative Diabetic Healthcare
Digital Diagnostics Names Chris Meenan as Chief Technology Officer
High Quality Home Studio Setup with Michael Abramoff
Digital Diagnostics Partners with Rapidly Scaling Medicare Advantage Organization, ArchWell Health
Digital Diagnostics, Kingdom of Saudi Arabia Sign Intent to Provide Preventative Diabetic Healthcare to 35M
Digital Diagnostics hosted the Congressional Healthy Futures Task Force, Modernization Subcommittee
AWS (Internet of Things) IoT
8 Questions to Ask When Evaluating an Autonomous AI System that Detects Diabetic Retinopathy
Do People with Diabetes Avoid Diabetic Eye Exams?
What is Diabetic Retinopathy: How Primary Care Can Protect Patients with Diabetes
Digital Diagnostics and Baxter Announce New Partnership
Digital Diagnostics Celebrates CMS’s Historic Decision to Finalize a National Rate for CPT 92229
Digital Diagnostics Provides New Designation to Top Executives – Co-Founder Titles Added to Recognize Impact of Company Leaders
4 Essentials to Develop a Successful Health Care AI Solution
Digital Diagnostics Extends Appreciation to CMS for Improving Access to Innovative, Validated Healthcare AI Designed to Eliminate Disparities and Drive Equity
Identify Eye Disease Early at Your Family Doctor’s Office
In the Trenches of AI Commercialization
CMS Releases Proposed Changes to CY ’22 Medicare Physician Fee Schedule
Digital Diagnostics and Orbis International announce study to help save sight in Bangladesh
The A-Eye Visionary
Reducing Preventable Blindness is a Global Reality with an Orbis and Digital Diagnostics Partnership
How Artificial Intelligence is Primed to Change Ophthalmology
Infrastructure as Code Tool Selection
Digital Diagnostics Joins the Population Health Alliance, Paving the Way Toward Autonomous AI Diagnostics
Building a Platform Strategy
George Barrett, former Cardinal Health, Inc. Chairman and Chief Executive Officer, Joins Digital Diagnostics Board of Directors
Identifying Ethical Considerations for Machine Learning Healthcare Applications
If we’re serious about healthcare equity and access, we must support autonomous AI
IDx rebrands to lead AI health care revolution
AI-Based Point-of-Care Pediatric DR Screenings May Improve Diagnosis Rates
Digital Diagnostics: Committed to Ethical AI Healthcare
Pre-2012 startups and AI products across medical specialties
The use of AI systems contributes to an optimization of the time that doctor dedicates to each patient
AMA Releases 2021 CPT Code Set
Digital Diagnostics dubs UAE an emerging market for AI healthcare solutions
AI company that got first-of-its-kind FDA device approval makes acquisition
3Derm is acquired!
Digital Diagnostics, formerly IDx, Expands Global Impact of Healthcare Autonomous AI with Acquisition of 3Derm Systems, Inc.
Historic Proposed CMS Rule Will Allow First-Ever Reimbursement of Autonomous AI in a Healthcare Setting
Milestone Population Health Measure Clarification from NCQA Expands Sight-Saving Access to Early Diagnosis of Diabetic Retinopathy and Macular Edema Through Autonomous AI
Newly published ethical guidelines for when a computer makes a clinical diagnosis
ATA releases new guidelines that include artificial intelligence diagnosis
How Autonomous Diagnostics For DR Gave A ‘Jump-Start’ To AI In Ophthalmology
Artificial Intelligence for the Diagnosis of Diabetic Retinopathy: An Interview With Michael D. Abramoff, MD, PhD
The Algorithm Will See You Now
Autonomous in Action
A Reality Check On Artificial Intelligence: Are Health Care Claims Overblown?
2020 ADA Standards of Care just arrived and now includes AI to prevent blindness
With New CEO, Artificial Intelligence Start-Up Expects 2020 To Be ‘Year Of Mass Adoption’
Surge of growth has IDx build new executive team
AI Screening for Diabetic Retinopathy Moves to Retail Clinics
Autonomous AI diagnostics launch in retail health clinics
LumineticsCore™ (formerly known as IDx-DR), the First FDA-Approved AI System, is Growing Rapidly
Primary Care Doctors Identify Patients with Eye Disease Using Artificial Intelligence
IDx Taps Former LabCorp Executive to Lead Sales and Customer Success
How to Choose the Reference Standard for an AI Clinical Trial
IDx is the only company named to CB Insights Digital Health 150 with an FDA-cleared autonomous AI diagnostic
Family Medicine specialists use AI to save the sight of diabetic patients
Treating Diabetic Retinopathy
This ophthalmologist is doing health care AI the right way
Autonomous AI Device Receives Historic CPT Code
AI in Medtech: Innovating in An Era of Uncertainty
Get ready for AI in health care: Here is the outlook
5 burning questions about using artificial intelligence to prevent blindness
What your patients can expect during a diabetic retinopathy exam
New CPT code for Automated Point-of-care Retinal Imaging
The AMA paves the way for AI innovation with new policy recommendations
The biggest hurdle to creating an AI for glaucoma detection
How to Successfully Complete Comprehensive Diabetes Care Documentation
Diabetic Retinopathy Exams in Primary Care
Everything You Need to Know Right Now About AI in Medtech
How Can We Be Sure Artificial Intelligence Is Safe For Medical Use?
Artificial intelligence and medicine: Is it overhyped?
Photos: Andrew Yang visits AI diagnostics company IDx Technologies Inc. in Coralville
Diabetic Retinopathy Now Being Tested For More With Artificial Intelligence
Diabetes Patients Now Being Tested with AI in More Settings
WorldCanvass: Artificial Intelligence (Audio)
AI 100: The Artificial Intelligence Startups Redefining Industries
Augmenting Human Expertise in Medicine and Healthcare (Video)
FierceHealthcare’s Fierce 15 of 2019
Physician CEO discusses benefits, challenges to AI in medicine at FTC hearing
Medgadget’s Best Medical Technologies of 2018
IDx is Ready for AI to Break Through in 2019
A Year in the Life of a Trailblazing AI Healthcare Company
A-EYE
How AI-based Systems Can Improve Medical Outcomes
FTC hearing: Not all AI is created equal, so safety and validation are critical
FTC Seeks Expert Advice from IDx CEO on Safely Introducing Real-World AI
Topcon’s Harmony imaging platform users in Europe now have access to LumineticsCore™ (formerly known as IDx-DR)
IDx and Topcon sign exclusive AI platform agreement for the U.S. market
AI alone now making the diagnosis
AI Diagnostics Company IDx Secures Significant Funding From 8VC, Optum Ventures
AI diagnostic system accuracy holds up to industry standards
The first AI approved to diagnose disease is tackling blindness in rural areas
Pivotal trial results behind the FDA’s first ever clearance of an autonomous AI diagnostic system published in Nature Digital Medicine
AI Speeds Diabetic Retinopathy Diagnosis Without Specialist
How AI Technology Is Helping Make Healthcare More Accessible And Affordable
Coralville Based IDx LLC Aims to Change Health Care Delivery
How IDx is Paving the Way for AI Use in Medicine
Could Artificial Intelligence Replace Doctors? AI Is Now Diagnosing This Common Eye Disease
AI & Ophthalmology: Two Approaches to Diagnosis
AI-based device an example of innovation at work
CONVERSATIONS IN RETINA: A Conversation With Michael Abramoff, MD, PhD
University of Iowa Health Care first to adopt LumineticsCore™ (formerly known as IDx-DR) in a diabetes care setting
Autonomous vs. Assistive AI: How to unlock real value in healthcare
Interview with Dr. Michael Abramoff, President of IDx
How AI can potentially close a care gap for people with diabetes
FDA Approves Marketing of Device That Can Help Detect Irreversible Diabetic Retinopathy
The FDA just opened the door to let AI make medical decisions on its own
FDA permits marketing of LumineticsCore™ (formerly known as IDx-DR) for automated detection of diabetic retinopathy in primary care
IDx founder awarded patent for system that automatically detects measure of cardiovascular health
In the future, an AI may diagnose eye problems
AI Diagnostics Move Into the Clinic
This AI screening tool for diabetic retinopathy makes a decision, not a recommendation
FDA to expedite review of LumineticsCore™ (formerly known as IDx-DR), a breakthrough AI diagnostic system
IDx founder speaks to Congress about how to spur innovation
